drugset / Trial / NCT01340131
CKD-828 (40/5mg) Pharmacokinetic Study
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics of CKD-828 (Fixed Dose Combination Tablet; Telmisartan and S-Amlodipine) in healthy volunteer.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-03
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-amlodipine | Unknown | 5 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |